Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly t(16;21)(p11;q22). (A chromosomal translocation involving the FUS gene on chromosome 16p11 and the ERG gene on chromosome 21q22.)
No clinical trials have been registered for acute myeloid leukemia, t(16;21)(p11;q22).
5 publications have been identified in PubMed for acute myeloid leukemia, t(16;21)(p11;q22). Research spans Basic Science / Preclinical (60%), Case Report / Case Series (20%), and Clinical Trial Publication (20%).
Shi L (2026). [PMID: 41663298](https://pubmed.ncbi.nlm.nih.gov/41663298/). *Zhonghua Yi Xue Yi Chuan Xue Za Zhi*. [Case Report / Case Series]
Bravo-Davila M (2026). [PMID: 41822316](https://pubmed.ncbi.nlm.nih.gov/41822316/). *World J Oncol*. [Basic Science / Preclinical]
Buteyn NJ (2025). [PMID: 38798454](https://pubmed.ncbi.nlm.nih.gov/38798454/). *bioRxiv*. [Basic Science / Preclinical]
Mitsuyuki S (2025). [PMID: 39658629](https://pubmed.ncbi.nlm.nih.gov/39658629/). *Leukemia*. [Clinical Trial Publication]
Lai A (2024). [PMID: 38742238](https://pubmed.ncbi.nlm.nih.gov/38742238/). *Blood Sci*. [Basic Science / Preclinical]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:39 PM UTC
Common questions about acute myeloid leukemia, t(16;21)(p11;q22)